Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Borrow

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
International Journal of Immunogenetics|February 3, 2012
Genetic susceptibility to invasive meningococcal disease: MBL2 structural polymorphisms revisited in a large case-control study and a systematic reviewD T Bradley, T W Bourke, D J Fairley, et al.
Journal of Public Health (Oxford, England)|March 7, 2015
Variations in Neisseria meningitidis carriage by socioeconomic status: a cross-sectional studyP R Cleary, N Calvert, S Gee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2010
Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trialK P Perrett, A P Winter, E Kibwana, et al.
FEMS Immunology and Medical Microbiology|April 18, 2000
Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccineR Borrow, P Richmond, E B Kaczmarski, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 1, 2014
MBL2 deficiency is associated with higher genomic bacterial loads during meningococcemia in young childrenT C Darton, D L Jack, M Johnson, et al.
Vaccine|February 13, 2026
Immunogenicity and safety of two doses of the four-component recombinant meningococcal B (4CMenB) vaccine in adults with immunodeficiencyL Sticchi, A Di Biagio, A Domnich, et al.
The Journal of Infectious Diseases|October 7, 2000
An interleukin-1 genotype is associated with fatal outcome of meningococcal diseaseR C Read, N J Camp, F S di Giovine, et al.
The Journal of Infectious Diseases|August 9, 2001
A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal diseaseR C Read, J Pullin, S Gregory, et al.
Clinical and Vaccine Immunology : CVI|February 6, 2015
Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodiesS Blumental, J C Moïsi, L Roalfe, et al.
The Journal of Infection|December 21, 2022
Following the Omicron wave, the majority of children in England have evidence of previous COVID infectionC Oeser, H Whitaker, R Borrow, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
International Journal of Immunogenetics|February 3, 2012
Genetic susceptibility to invasive meningococcal disease: MBL2 structural polymorphisms revisited in a large case-control study and a systematic reviewD T Bradley, T W Bourke, D J Fairley, et al.
Journal of Public Health (Oxford, England)|March 7, 2015
Variations in Neisseria meningitidis carriage by socioeconomic status: a cross-sectional studyP R Cleary, N Calvert, S Gee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2010
Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trialK P Perrett, A P Winter, E Kibwana, et al.
FEMS Immunology and Medical Microbiology|April 18, 2000
Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccineR Borrow, P Richmond, E B Kaczmarski, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 1, 2014
MBL2 deficiency is associated with higher genomic bacterial loads during meningococcemia in young childrenT C Darton, D L Jack, M Johnson, et al.
Vaccine|February 13, 2026
Immunogenicity and safety of two doses of the four-component recombinant meningococcal B (4CMenB) vaccine in adults with immunodeficiencyL Sticchi, A Di Biagio, A Domnich, et al.
The Journal of Infectious Diseases|October 7, 2000
An interleukin-1 genotype is associated with fatal outcome of meningococcal diseaseR C Read, N J Camp, F S di Giovine, et al.
The Journal of Infectious Diseases|August 9, 2001
A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal diseaseR C Read, J Pullin, S Gregory, et al.
Clinical and Vaccine Immunology : CVI|February 6, 2015
Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodiesS Blumental, J C Moïsi, L Roalfe, et al.
The Journal of Infection|December 21, 2022
Following the Omicron wave, the majority of children in England have evidence of previous COVID infectionC Oeser, H Whitaker, R Borrow, et al.
Pageof 10